Figure 4.
HSCT removes EBV-infected cells from the hematopoietic system. (A) UMAP showing that HSCT cleared out EBV infection from the hematopoietic system of the patient with CAEBV (subject 4) after HSCT. Red dots in the UMAP represent the EBV-infected cells. For comparison, the UMAP for the pre-HSCT sample of the same patient is shown in supplemental Figure 4H. (B) Pie charts showing the percentages of the EBV-infected cells in each hematopoietic cell population of the patient with CAEBV (subject 4) after HSCT. B, B cells; Baso, basophils; CMP, common myeloid progenitors; CLP, common lymphoid progenitors; DC, dendritic cells; Ery, erythrocytes; EryP, erythroid progenitors; GMP, granulocyte-monocyte progenitors; MEP, megakaryocyte/erythroid progenitors; Mk, megakaryocytes; Mono, monocytes; Myelo, myelocytes; Neutro, neutrophils; T, T cells.

HSCT removes EBV-infected cells from the hematopoietic system. (A) UMAP showing that HSCT cleared out EBV infection from the hematopoietic system of the patient with CAEBV (subject 4) after HSCT. Red dots in the UMAP represent the EBV-infected cells. For comparison, the UMAP for the pre-HSCT sample of the same patient is shown in supplemental Figure 4H. (B) Pie charts showing the percentages of the EBV-infected cells in each hematopoietic cell population of the patient with CAEBV (subject 4) after HSCT. B, B cells; Baso, basophils; CMP, common myeloid progenitors; CLP, common lymphoid progenitors; DC, dendritic cells; Ery, erythrocytes; EryP, erythroid progenitors; GMP, granulocyte-monocyte progenitors; MEP, megakaryocyte/erythroid progenitors; Mk, megakaryocytes; Mono, monocytes; Myelo, myelocytes; Neutro, neutrophils; T, T cells.

Close Modal

or Create an Account

Close Modal
Close Modal